Pain, Procedural
Conditions
Brief summary
The study is designed as a randomized controlled trial with two parallel groups. Children aged 5-9 years with primary molars from suffered symptomatic signs of irreversible pulpitis will be randomly assigned into two groups. The first group (experimental group) will be injected with 4% articaine 1:100.000 epinephrine (inferior alveolar nerve block). For the second group, the mandibular second primary molars will be anesthetized using 4% articaine 1:100.000 epinephrine using inferior alveolar nerve block.
Interventions
local anesthetic injection with articaine 4% 1:100,000 epinephrine then an application ice packs
local anesthetic injection with articaine 4% 1:100,000 epinephrine
Sponsors
Study design
Eligibility
Inclusion criteria
* Healthy children are classified as I or II according to ASA * Presence of at least one mandibular primary molar with symptomatic signs of irreversible pulpitis * Presence of at least two-thirds of the root length in periapical radiograph
Exclusion criteria
* Unrestorable crowns * Children with systemic, severe behavior or emotional problems * Presence of gingival redness, swellings, fistulous of sinus tract * Radiographic evidence of internal root resorption, pulp stones or calcifications, and/or bone radiolucency
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Pain assessment | up to 24 hours | Wong Backer pain scale |
Countries
Egypt